Benvenue Medical completes divestiture of its vertebral augmentation systems portfolio

228

Benvenue MedicalBenvenue Medical, a developer of minimally invasive expandable implant solutions for lumbar fusion, has announced it has completed the divestiture of its vertebral augmentation systems portfolio for an undisclosed amount to IZI Medical Products. A company press release states that the completion of the sale of this business allows Benvenue Medical to devote its full resources to accelerating growth opportunities in the market for its Luna 3D interbody fusion system.

The divested portfolio includes the Kiva VCF [vertebral compression fracture] treatment system, Kiva Pilot and Blazer vertebral augmentation system devices.

“IZI Medical’s acquisition of the Kiva and associated VCF product franchise allows us to singularly focus on our minimally invasive spinal implant and procedure product line,” says Robert K Weigle, CEO of Benvenue Medical. “Our best-in-class Luna 3D expandable interbody system is an ideal minimally invasive expandable spinal implant and platform technology, enabling Nitinol, PEEK and Titanium materials to be combined in a procedural solution for degenerative disc disease that can be treated in either the hospital or the ambulatory surgery centre setting.”

Benvenue Medical also announced the addition of its new Orbit discectomy instrumentation that facilitates a circumferential and comprehensive discectomy and endplate preparation to achieve a fusion. This novel new tool kit can be used in open and minimally invasive surgery with the Luna 3D implants, including compatibility with a variety of surgical fusion approaches.

Benvenue Medical is privately held and funded by CRG.

(Visited 55 times, 1 visits today)

LEAVE A REPLY

Please enter your comment!
Please enter your name here